JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on October 6, 2006; DOI: 10.1124/jpet.106.112748


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.112748v1
320/1/117    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jackson, E. K.
Right arrow Articles by Dubey, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jackson, E. K.
Right arrow Articles by Dubey, R. K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH


Received for publication August 24, 2006.
Revised October 5, 2006.
Accepted for publication October 5, 2006.

The Extracellular cAMP-Adenosine Pathway Significantly Contributes To The In Vivo Production Of Adenosine

Edwin K. Jackson 1*, Zaichuan Mi 1, Raghvendra K. Dubey 1

1 University of Pittsburgh School of Medicine

* Address correspondence to: E-mail: edj{at}pitt.edu

Abstract

The extracellular cAMP-adenosine pathway is the cellular egress of cAMP followed by extracellular conversion of cAMP to adenosine by the sequential actions of ecto-phosphodiesterase and ecto-5'-nucleotidase. Although detailed studies in isolated organs, tissues and cells provide evidence for an extracellular cAMP-adenosine pathway, whether this mechanism contributes significantly to adenosine production in vivo is unclear. 1,3-Dipropyl-8-p-sulfophenylxanthine is restricted to the extracellular compartment due to a negative charge at physiological pH, and at high concentrations (≥0.1 mmoles/L) blocks ecto-phosphodiesterase. Here we show that administration of 1,3-dipropyl-8-p-sulfophenylxanthine at a dose that provided concentrations in plasma and urine of approximately 0.3 mmoles/L and 6 mmoles/L, respectively, inhibited urinary adenosine excretion. In Sprague-Dawley rats, intravenous 1,3-dipropyl-8-p-sulfophenylxanthine (10 mg + 0.15 mg/min) significantly decreased by 48% and 39% the urinary excretion of adenosine (from 3.57 ± 0.38 to 1.87 ± 0.14 nmoles/30 min; P=0.0003) and the ratio of urinary adenosine to cAMP (from 0.93 ± 0.08 to 0.57 ± 0.06; P=0.0044), respectively, without altering blood pressure, renal blood flow or glomerular filtration rate. Although 1,3-dipropyl-8-p-sulfophenylxanthine transiently increased urine volume and sodium excretion, these effects subsided, yet adenosine excretion remained reduced. Thus changes in systemic and renal hemodynamics and excretory function could not account for the effects of 1,3-dipropyl-8-p-sulfophenylxanthine on adenosine excretion. Additional experiments showed that 1,3-dipropyl-8-p-sulfophenylxanthine, as in Sprague-Dawley rats, significantly attenuated adenosine excretion and the ratio of urinary adenosine to cAMP in both Wistar-Kyoto rats and spontaneously hypertensive rats. We conclude that the extracellular cAMP-adenosine pathway significantly contributes to the in vivo production of adenosine.


Key words: 1,3-Dipropyl-8-p-sulfophenylxanthine, Adenosine, Cyclic AMP, Ecto-5'-Nucleotidase, Ecto-Phosphodiesterase, Phosphodiesterase


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Franco, R. Bautista, O. Perez-Mendez, L. Gonzalez, U. Pacheco, L. G. Sanchez-Lozada, J. Santamaria, E. Tapia, R. Monreal, and F. Martinez
Renal interstitial adenosine is increased in angiotensin II-induced hypertensive rats
Am J Physiol Renal Physiol, January 1, 2008; 294(1): F84 - F92.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
A. M. Hofer and K. Lefkimmiatis
Extracellular Calcium and cAMP: Second Messengers as "Third Messengers"?
Physiology, October 1, 2007; 22(5): 320 - 327.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.